Stock listing
NASDAQ:INTS Intensity Therapeutics, Inc. Stock
Home listing (NASDAQ) of Intensity Therapeutics, Inc.
Follow Intensity Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:INTS
$3.40 USD +0.06 (+1.8%)
Close on Oct 30, 2026
- Day range
- $3.21 – $3.46 USDOct 30, 2026
- Volume
- 16,111 sharesOct 30, 2026
- Market cap
- $11.10M USDAt the close on Oct 30, 2026 · price × 3.26M shares outstanding
- 52-week range
- $3.00 – $28.75 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $102,287 USDMedian day 15,350 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INTS · Home | $3.40 USD | +0.06 (+1.8%) | 16,111 | $3.40 | $3.455 | $3.21 | $3.34 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:INTS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.40 | +0.06 | +1.8% | $3.40 | $3.455 | $3.21 | 16,111 | |
| $3.34 | -0.04 | -1.2% | $3.39 | $3.43 | $3.14 | 7,648 | |
| $3.38 | +0.20 | +6.3% | $3.28 | $3.38 | $3.28 | 1,366 | |
| $3.18 | -0.02 | -0.6% | $3.13 | $3.195 | $3.10 | 15,283 | |
| $3.20 | -0.05 | -1.5% | $3.20 | $3.24 | $3.00 | 10,272 | |
| $3.25 | +0.06 | +1.9% | $3.14 | $3.31 | $3.14 | 6,412 | |
| $3.19 | +0.047 | +1.5% | $3.22 | $3.509 | $3.09 | 6,838 | |
| $3.143 | -0.137 | -4.2% | $3.25 | $3.51 | $3.13 | 9,846 | |
| $3.28 | -0.01 | -0.3% | $3.31 | $3.31 | $3.25 | 2,592 | |
| $3.29 | -0.06 | -1.8% | $3.21 | $3.295 | $3.15 | 7,192 | |
| $3.35 | -0.03 | -0.9% | $3.40 | $3.40 | $3.14 | 32,300 | |
| $3.38 | -0.04 | -1.2% | $3.35 | $3.55 | $3.35 | 8,300 | |
| $3.42 | -0.13 | -3.7% | $3.56 | $3.58 | $3.293 | 25,900 | |
| $3.55 | +0.24 | +7.3% | $3.20 | $4.04 | $3.097 | 123,700 | |
| $3.31 | -0.32 | -8.8% | $3.70 | $3.70 | $3.14 | 42,000 | |
| $3.63 | -0.05 | -1.4% | $3.75 | $3.75 | $3.55 | 16,700 | |
| $3.68 | -0.12 | -3.2% | $3.76 | $3.80 | $3.58 | 19,200 | |
| $3.80 | +0.25 | +7.0% | $3.47 | $3.87 | $3.463 | 17,200 | |
| $3.55 | +0.10 | +2.9% | $3.34 | $3.67 | $3.34 | 7,500 | |
| $3.45 | +0.01 | +0.3% | $3.45 | $3.75 | $3.45 | 28,800 | |
| $3.44 | +0.23 | +7.2% | $3.27 | $3.45 | $3.21 | 15,400 | |
| $3.21 | -0.16 | -4.7% | $3.36 | $3.563 | $3.21 | 15,300 | |
| $3.37 | -0.05 | -1.5% | $3.40 | $3.457 | $3.275 | 20,900 | |
| $3.42 | -0.23 | -6.3% | $3.70 | $3.70 | $3.27 | 34,000 | |
| $3.65 | -0.15 | -3.9% | $3.90 | $3.90 | $3.63 | 36,200 | |
| $3.80 | -0.09 | -2.3% | $4.096 | $4.096 | $3.80 | 8,400 | |
| $3.89 | -0.21 | -5.1% | $4.18 | $4.18 | $3.89 | 10,600 | |
| $4.10 | +0.09 | +2.2% | $3.98 | $4.10 | $3.98 | 4,100 | |
| $4.01 | -0.01 | -0.2% | $4.01 | $4.11 | $3.888 | 14,700 | |
| $4.02 | -0.09 | -2.2% | $4.24 | $4.30 | $4.02 | 6,400 | |
| $4.11 | +0.23 | +5.9% | $3.79 | $4.29 | $3.79 | 45,100 | |
| $3.88 | +0.07 | +1.8% | $3.989 | $3.989 | $3.79 | 8,300 | |
| $3.81 | 0.00 | 0.0% | $3.821 | $3.93 | $3.75 | 8,300 | |
| $3.81 | -0.17 | -4.3% | $3.95 | $3.98 | $3.81 | 3,900 | |
| $3.98 | -0.04 | -1.0% | $3.959 | $4.053 | $3.90 | 37,200 | |
| $4.02 | -0.02 | -0.5% | $4.10 | $4.118 | $3.98 | 10,500 | |
| $4.04 | +0.02 | +0.5% | $4.04 | $4.06 | $4.04 | 2,300 | |
| $4.02 | -0.07 | -1.7% | $4.12 | $4.12 | $3.99 | 6,000 | |
| $4.09 | -0.01 | -0.2% | $4.07 | $4.13 | $4.06 | 11,600 | |
| $4.10 | +0.10 | +2.5% | $3.99 | $4.11 | $3.99 | 4,500 | |
| $4.00 | 0.00 | 0.0% | $4.12 | $4.12 | $4.00 | 10,000 | |
| $4.00 | -0.07 | -1.7% | $4.10 | $4.146 | $4.00 | 14,200 | |
| $4.07 | -0.14 | -3.3% | $4.18 | $4.18 | $4.02 | 23,700 | |
| $4.21 | -0.04 | -0.9% | $4.271 | $4.28 | $4.20 | 6,400 | |
| $4.25 | -0.02 | -0.5% | $4.30 | $4.579 | $4.22 | 22,400 | |
| $4.27 | -0.26 | -5.7% | $4.59 | $4.70 | $4.19 | 75,200 | |
| $4.53 | -0.365 | -7.5% | $4.83 | $5.075 | $4.36 | 126,300 | |
| $4.895 | +0.145 | +3.1% | $4.71 | $5.17 | $4.695 | 103,893 | |
| $4.75 | -0.11 | -2.3% | $4.57 | $4.86 | $4.57 | 26,899 | |
| $4.86 | -0.02 | -0.4% | $4.89 | $4.89 | $4.531 | 20,200 | |
| $4.88 | +0.68 | +16.2% | $4.16 | $4.91 | $4.16 | 68,800 | |
| $4.20 | -0.01 | -0.2% | $4.25 | $4.33 | $4.20 | 17,200 | |
| $4.21 | +0.06 | +1.4% | $4.13 | $4.37 | $4.13 | 8,300 | |
| $4.15 | +0.19 | +4.8% | $3.96 | $4.169 | $3.94 | 24,800 | |
| $3.96 | -0.04 | -1.0% | $4.01 | $4.19 | $3.901 | 38,900 | |
| $4.00 | -0.16 | -3.8% | $4.07 | $4.20 | $3.93 | 53,400 | |
| $4.16 | -0.04 | -1.0% | $4.11 | $4.34 | $4.10 | 15,300 | |
| $4.20 | -0.09 | -2.1% | $4.17 | $4.35 | $4.12 | 26,300 | |
| $4.29 | +0.13 | +3.1% | $4.19 | $4.35 | $4.15 | 14,500 | |
| $4.16 | -0.09 | -2.1% | $4.53 | $4.53 | $4.16 | 22,400 | |
| $4.25 | +0.05 | +1.2% | $4.21 | $4.34 | $4.21 | 12,400 | |
| $4.20 | +0.02 | +0.5% | $4.00 | $4.325 | $3.995 | 64,700 | |
| $4.18 | -0.08 | -1.9% | $4.28 | $4.28 | $4.15 | 33,100 | |
| $4.26 | +0.11 | +2.7% | $4.09 | $4.39 | $4.09 | 12,000 | |
| $4.15 | +0.10 | +2.5% | $4.01 | $4.55 | $4.01 | 78,100 | |
| $4.05 | -0.28 | -6.5% | $4.31 | $4.42 | $4.008 | 44,400 |
- Ticker
- NASDAQ:INTS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026
Latest earnings call · Aug 11, 2026
Intensity Therapeutics (NASDAQ:INTS) Q2 2026 Earnings Call
Replay and transcript
Calls
Upcoming
Intensity Therapeutics (NASDAQ:INTS) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 8:00 AM ET
Register
Replays
Intensity Therapeutics (NASDAQ:INTS) Q2 2026 Earnings Call
Tue, Aug 11, 2026 · 8:00 AM ET
Watch TranscriptIntensity Therapeutics (NASDAQ:INTS) Q2 2023 Earnings Call
Mon, Aug 14, 2023 · 8:00 AM ET
Watch Transcript
Latest news
Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026
Oct 30, 2026
Closed $3.40 (+1.8%) on Oct 30, 2026
Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting
Oct 23, 2026
Closed $3.25 (+1.9%) on Oct 23, 2026
Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO...
Oct 23, 2026
Closed $3.25 (+1.9%) on Oct 23, 2026
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $4.09 (-0.2%) on Sep 8, 2026
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026
Closed $4.20 (-2.1%) on Aug 11, 2026
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
Aug 4, 2026
Closed $4.18 (-1.9%) on Aug 4, 2026
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
Jul 15, 2026
Closed $4.84 (-0.6%) on Jul 15, 2026
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
Closed $5.09 (-0.4%) on May 8, 2026
Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation
Apr 15, 2026
Closed $5.30 (-1.1%) on Apr 15, 2026
Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update
Mar 27, 2026
Closed $6.03 (-1.3%) on Mar 27, 2026
Decks
IPO Roadshow (June 2025)
IPO roadshow · 28 slides · Jun 11, 2025
Investor Presentation (April 2025)
Investor deck · 28 slides · Apr 23, 2025
IPO Roadshow (April 2025)
IPO roadshow · 29 slides · Apr 23, 2025
CTOS Annual Meeting 2024
Conference · 11 slides · 2024
Intensity Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 73 in all · newest Oct 30, 2026 · oldest 2022
- Calls
- 2 calls with a replay · 2 with a transcript · latest Aug 11, 2026
- Decks
- 14 decks · latest Jun 11, 2025
Where Intensity Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INTS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:INTS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Intensity Therapeutics, Inc.